{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:03:47Z","timestamp":1790964227348,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008846.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000}}],"reference-count":97,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008846.pub3","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T14:26:16Z","timestamp":1632925576000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Mass drug administration for malaria"],"prefix":"10.1002","volume":"2021","author":[{"given":"Monica P","family":"Shah","sequence":"additional","affiliation":[{"name":"Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health; Centers for Disease Control and Prevention; Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimee","family":"Hwang","sequence":"additional","affiliation":[{"name":"U.S. President\u2019s Malaria Initiative, Malaria Branch; Centers for Disease Control and Prevention; Atlanta GA USA"},{"name":"Global Health Group; University of California San Francisco; San Francisco USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Vector Biology; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A","family":"Lindblade","sequence":"additional","affiliation":[{"name":"Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health; Centers for Disease Control and Prevention; Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Patrick","family":"Kachur","sequence":"additional","affiliation":[{"name":"Department of Population and Family Health; Columbia University Medical Center; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Desai","sequence":"additional","affiliation":[{"name":"Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health; Centers for Disease Control and Prevention; Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"issue":"2_Suppl","key":"10.1002\/14651858.CD008846.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4269\/ajtmh.19-0657","article-title":"A longitudinal cohort to monitor malaria infection incidence during mass drug administration in Southern Province, Zambia","volume":"103","author":"Bennett","year":"2020","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0002|cit2","first-page":"487","article-title":"Adverse event reporting from malaria mass drug administration rounds conducted in Southern Zambia","volume":"95","author":"Chalwe","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0003|cit3","first-page":"501","article-title":"Programmatic mass drug administration in Southern Province, Zambia: An evaluation of impact and possible spill-over effects using dhis2 malaria case incidence data","volume":"97","author":"Conner","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2_Suppl","key":"10.1002\/14651858.CD008846.pub3-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4269\/ajtmh.19-0659","article-title":"Impact of four rounds of mass drug administration with dihydroartemisinin-piperaquine implemented in southern province, Zambia","volume":"103","author":"Finn","year":"2020","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4 Supplement","key":"10.1002\/14651858.CD008846.pub3-BIB0005|cit5","first-page":"83","article-title":"The impact of targeted mass drug administration using dihydroartemisinin-piperaquine in southern province Zambia: initial findings","volume":"93","author":"Eisele","year":"2015","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"12","key":"10.1002\/14651858.CD008846.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/infdis\/jiw416","article-title":"Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in southern province Zambia: a cluster-randomized controlled trial","volume":"214","author":"Eisele","year":"2016","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13063-015-0862-3","article-title":"Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial","volume":"16","author":"Eisele","year":"2015","journal-title":"Trials"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0008|cit8","first-page":"593","article-title":"PCR incidence of plasmodium falciparum infections in cohort samples over time during a malaria MDA randomized control trial in southern province Zambia","volume":"97","author":"Mwenda","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2_Suppl","key":"10.1002\/14651858.CD008846.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4269\/ajtmh.19-0657","article-title":"A longitudinal cohort to monitor malaria infection incidence during mass drug administration in southern province, Zambia","volume":"103","author":"Bennett","year":"2020","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0010|cit10","first-page":"487","article-title":"Adverse event reporting from malaria mass drug administration rounds conducted in Southern Zambia","volume":"95","author":"Chalwe","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0011|cit11","first-page":"501","article-title":"Programmatic mass drug administration in southern province, Zambia: an evaluation of impact and possible spill-over effects using dhis2 malaria case incidence data","volume":"97","author":"Conner","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2_Suppl","key":"10.1002\/14651858.CD008846.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4269\/ajtmh.19-0659","article-title":"Impact of four rounds of mass drug administration with dihydroartemisinin-piperaquine implemented in southern province, Zambia","volume":"103","author":"Finn","year":"2020","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4 Supplement","key":"10.1002\/14651858.CD008846.pub3-BIB0013|cit13","first-page":"83","article-title":"The impact of targeted mass drug administration using dihydroartemisinin-piperaquine in southern province Zambia: initial findings","volume":"93","author":"Eisele","year":"2015","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"12","key":"10.1002\/14651858.CD008846.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/infdis\/jiw416","article-title":"Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in southern province Zambia: a cluster-randomized controlled trial","volume":"214","author":"Eisele","year":"2016","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s13063-015-0862-3","article-title":"Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence \u00a0in southern province, Zambia: study protocol for a community randomized controlled trial","volume":"16","author":"Eisele","year":"2015","journal-title":"Trials"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0016|cit16","first-page":"593","article-title":"PCR incidence of Plasmodium falciparum infections in cohort samples over time during a malaria MDA randomized control trial in southern province Zambia","volume":"97","author":"Mwenda","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD008846.pub3-BIB0017|cit17","first-page":"268","article-title":"Results of mass antimalarial chemoprophylaxis with a combination of 4-aminoquinoline and 8-aminoquinoline under rural African conditions in the region of Bobo-Dioulasso (Upper Volta) 1960. Comparative study in a zone treated with DDT and outside this zone","volume":"22","author":"Escudie","year":"1962","journal-title":"Medecine Tropicale"},{"issue":"5","key":"10.1002\/14651858.CD008846.pub3-BIB0018|cit18","first-page":"1012","article-title":"Eradication of malaria and chemotherapy. Results obtained with the association amino-4 quinoline + amino-8 quinoline in the pilot area of Bobo-Dioulasso (Haute- Volta)","volume":"54","author":"Schneider","year":"1961","journal-title":"Bulletin de la Societe de Pathologie Exotique"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12688\/wellcomeopenres.12240.1","article-title":"Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: a pilot trial in four villages of Eastern Myanmar","volume":"2","author":"Landier","year":"2017","journal-title":"Wellcome Open Research"},{"issue":"2","key":"10.1002\/14651858.CD008846.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"e1002745","DOI":"10.1371\/journal.pmed.1002745","article-title":"The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in South-East Asia: a cluster randomised trial","volume":"16","author":"Seidlein","year":"2019","journal-title":"PLoS Medicine"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0021|cit21","first-page":"411","article-title":"Speeding up malaria elimination; a cluster randomized controlled trial of mass drug administration in Southeast Myanmar, an area with artemisinin resistance","volume":"97","author":"Heaton","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0022|cit22","unstructured":"McLean AR Indrasuta C Khant ZS Phyo AK Maung SM Heaton J Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial Lancet Infectious Diseases 10.1016\/S1473-3099(20)30997-X"},{"issue":"4","key":"10.1002\/14651858.CD008846.pub3-BIB0023|cit23","first-page":"579","article-title":"Changing patterns in the humoral immune response to malaria before, during and after the application of control measures: a longitudinal study in the West African savanna","volume":"56","author":"Brogger","year":"1978","journal-title":"Bulletin of the World Health Organization"},{"issue":"4","key":"10.1002\/14651858.CD008846.pub3-BIB0024|cit24","first-page":"573","article-title":"Longitudinal serological study of malaria in infants in the West African savanna. Comparisons in infants exposed to, or protected from, transmission from birth","volume":"56","author":"Molineaux","year":"1978","journal-title":"Bulletin of the World Health Organisation"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0025|cit25","unstructured":"Molineaux L Gramiccia G The Garki Project. Research on the epidemiology and control of malaria in the Sudan Savanna of West Africa. 1980 https:\/\/apps.who.int\/iris\/handle\/10665\/40316"},{"issue":"5","key":"10.1002\/14651858.CD008846.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4269\/ajtmh.1980.29.725","article-title":"A longitudinal study of human malaria in the West African savanna in the absence of control measures: relationships between different Plasmodium species, in particular P. falciparum and P. malariae","volume":"29","author":"Molineaux","year":"1980","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12916-018-1202-8","article-title":"A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission","volume":"16","author":"Morris","year":"2018","journal-title":"BMC Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008846.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12936-018-2541-9","article-title":"The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos","volume":"17","author":"Pongvongsa","year":"2018","journal-title":"Malaria Journal"},{"issue":"2","key":"10.1002\/14651858.CD008846.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"e1002745","DOI":"10.1371\/journal.pmed.1002745","article-title":"The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in South-East Asia: a cluster randomised trial","volume":"16","author":"Seidlein","year":"2019","journal-title":"PLoS Medicine"},{"issue":"9","key":"10.1002\/14651858.CD008846.pub3-BIB0030|cit30","first-page":"201","article-title":"Pyrimethamine (Daraprim) in the control of epidemic malaria","volume":"59","author":"Roberts","year":"1956","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"7","key":"10.1002\/14651858.CD008846.pub3-BIB0031|cit31","first-page":"161","article-title":"The control of epidemic malaria in the highlands of Western Kenya. Part I. Before the campaign","volume":"67","author":"Roberts","year":"1964","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"8","key":"10.1002\/14651858.CD008846.pub3-BIB0032|cit32","first-page":"191","article-title":"The control of epidemic malaria in the highlands of Western Kenya. Part II. The campaign","volume":"67","author":"Roberts","year":"1964","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"9","key":"10.1002\/14651858.CD008846.pub3-BIB0033|cit33","first-page":"230","article-title":"The control of epidemic malaria in the highlands of Western Kenya. Part III. After the campaign","volume":"67","author":"Roberts","year":"1964","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1475-2875-10-247","article-title":"A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania","volume":"10","author":"Shekalaghe","year":"2011","journal-title":"Malaria Journal"},{"issue":"5","key":"10.1002\/14651858.CD008846.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.01135-09","article-title":"In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A) individuals","volume":"54","author":"Shekalaghe","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD008846.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/ciy196","article-title":"A controlled trial of mass drug administration to interrupt transmission of multidrug-resistant falciparum malaria in Cambodian villages","volume":"67","author":"Tripura","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD008846.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"e1002745","DOI":"10.1371\/journal.pmed.1002745","article-title":"The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in South-East Asia: a cluster randomised trial","volume":"16","author":"Seidlein","year":"2019","journal-title":"PLoS Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008846.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-3156.2001.00723.x","article-title":"Community perceptions of a mass administration of an antimalarial drug combination in The Gambia","volume":"6","author":"De Martin","year":"2001","journal-title":"Tropical Medicine & International Health"},{"issue":"2","key":"10.1002\/14651858.CD008846.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0035-9203(03)90125-8","article-title":"The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia","volume":"97","author":"Seidlein","year":"2003","journal-title":"Transactions of the Royal Society of Tropical Medicine & Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD008846.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"e1002745","DOI":"10.1371\/journal.pmed.1002745","article-title":"The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in South-East Asia: a cluster randomised trial","volume":"16","author":"Seidlein","year":"2019","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008846.pub3-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12936-017-2027-1","article-title":"Control of malaria in the Comoro Islands over the past century","volume":"16","author":"Chakir","year":"2017","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12936-016-1493-1","article-title":"Impact of the mass drug administration for malaria in response to the Ebola outbreak in Sierra Leone","volume":"15","author":"Aregawi","year":"2016","journal-title":"Malaria Journal"},{"issue":"11","key":"10.1002\/14651858.CD008846.pub3-BIB0043|cit43","first-page":"1670","article-title":"Large-scale artemisinin-piperaquine mass drug administration with or without primaquine dramatically reduces malaria in a highly endemic region of Africa","volume":"67","author":"Deng","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"Numero special","key":"10.1002\/14651858.CD008846.pub3-BIB0044|cit44","first-page":"689","article-title":"Result of two years of antimalarial chemoprophylaxis in rural Africa in the pilot area of \u200b\u200bBobo-Dioulasso (Haute Volta)","volume":"21","author":"Escudie","year":"1961","journal-title":"Medecine Tropicale"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0045|cit45","unstructured":"Fraser M Miller JM Silumbe K Hainsworth M Mudenda M Hamainza B Evaluating the impact of programmatic mass drug administration for malaria in Zambia using routine incidence data Journal of Infectious Diseases 10.1093\/infdis\/jiaa434"},{"issue":"1","key":"10.1002\/14651858.CD008846.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12936-019-2832-9","article-title":"Setting the scene and generating evidence for malaria elimination in Southern Mozambique","volume":"18","author":"Aide","year":"2019","journal-title":"Malaria Journal"},{"issue":"8","key":"10.1002\/14651858.CD008846.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"e1003227","DOI":"10.1371\/journal.pmed.1003227","article-title":"A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study","volume":"17","author":"Galatas","year":"2020","journal-title":"PLoS Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008846.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0035-9203(58)90104-4","article-title":"Mass treatment with pyrimethamine: a study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya. September 1952-September 1953","volume":"52","author":"Jones","year":"1958","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0049|cit49","first-page":"101","article-title":"The impact of mass drug administration on submicroscopic malaria infection: A pilot study on Ngodhe Island in Lake Victoria, Kenya","volume":"97","author":"Kagaya","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD008846.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"19060","DOI":"10.1038\/s41598-019-55437-8","article-title":"Malaria resurgence after significant reduction by mass drug administration on Ngodhe Island, Kenya","volume":"9","author":"Kagaya","year":"2019","journal-title":"Scientific Reports"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0051|cit51","first-page":"197","article-title":"Sustainable malaria elimination on Aneityum Island, Vanuatu, 1991-2014","volume":"91","author":"Kaneko","year":"2014","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"P50","DOI":"10.1186\/1475-2875-13-S1-P50","article-title":"Community-directed malaria freedom on Aneityum Island, Vanuatu, 1991-2014","volume":"13","author":"Kaneko","year":"2014","journal-title":"Malaria Journal"},{"issue":"9241","key":"10.1002\/14651858.CD008846.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(00)03127-5","article-title":"Malaria eradication on islands","volume":"356","author":"Kaneko","year":"2000","journal-title":"Lancet"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0054|cit54","first-page":"381","article-title":"Relative contribution of generalized early diagnosis and treatment and of targeted mass treatment to elimination of Plasmodium falciparum malaria in Eastern Myanmar","volume":"95","author":"Landier","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"10133","key":"10.1002\/14651858.CD008846.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(18)30792-X","article-title":"Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme","volume":"391","author":"Landier","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.12688\/wellcomeopenres.12741.2","article-title":"Scale up of a Plasmodium falciparum elimination program and surveillance system in Kayin State, Myanmar (study protocol: version 2)","volume":"2","author":"Parker","year":"2017","journal-title":"Wellcome Open Research"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0057|cit57","first-page":"1218","article-title":"Impact of mass drug administration with dihydroartemisinin-piperaquine on malaria transmission in a highly seasonal transmission setting in the Gambia","volume":"95 (5 Supplemen","author":"Mwesigwa","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD008846.pub3-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"278-86","DOI":"10.1093\/cid\/ciy870","article-title":"Mass drug administration with dihydroartemisinin-piperaquine and malaria transmission dynamics in The Gambia - a prospective cohort study","volume":"69","author":"Mwesigwa","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"5 Supplement 1","key":"10.1002\/14651858.CD008846.pub3-BIB0059|cit59","first-page":"411","article-title":"Impact of two annual cycles of mass drug administration on temporal trends of clinical malaria","volume":"97","author":"Mwesigwa","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"817","key":"10.1002\/14651858.CD008846.pub3-BIB0060|cit60","first-page":"1","article-title":"Mass drug administration and DDT indoor-spraying as antimalarial measures in the northern savanna of Nigeria","volume":"73","author":"Najera","year":"1973","journal-title":"World Health Organization"},{"issue":"1","key":"10.1002\/14651858.CD008846.pub3-BIB0061|cit61","first-page":"27","article-title":"Suppressive treatment with amodiaquin","volume":"7","author":"Singh","year":"1953","journal-title":"Indian Journal of Malariology"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0062|cit62","unstructured":"Antimalarial treatments for clearing low density P. falciparum and its impact on malaria transmission clinicaltrials.gov\/ct2\/show\/NCT00646126"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0063|cit63","unstructured":"Protocol of study on the therapeutic tolerability of Artequick\/Femse\/Togo chictr.org.cn\/showprojen.aspx?proj=15217"},{"issue":"10086","key":"10.1002\/14651858.CD008846.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/S0140-6736(17)31376-4","article-title":"Renewed push to strengthen vector control globally","volume":"389","author":"Alonso","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD008846.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"54","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"Bhatt","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1002\/14651858.CD008846.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1016\/S2214-109X(17)30220-6","article-title":"Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study","volume":"5","author":"Brady","year":"2017","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1002\/14651858.CD008846.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/653208","article-title":"Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control","volume":"202","author":"Chaccour","year":"2010","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0069|cit69","doi-asserted-by":"crossref","unstructured":"Ivermectin treatment in humans for reducing malaria transmission Cochrane Database of Systematic Reviews 2021 6 10.1002\/14651858.CD013117.pub2","DOI":"10.1002\/14651858.CD013117.pub2"},{"issue":"9237","key":"10.1002\/14651858.CD008846.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12936-019-2906-8","article-title":"Mass drug administration can be a valuable addition to the malaria elimination toolbox","volume":"18","year":"2019","journal-title":"Malaria Journal"},{"issue":"8348","key":"10.1002\/14651858.CD008846.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(83)90523-8","article-title":"Changes in malaria incidence after mass drug administration in Nicaragua","volume":"2","author":"Garfield","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0073|cit73","unstructured":"Product label for Krintafel; patient information approved by the US Food and Drug Administration; July 2018 Available at www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210795s000lbl.pdf"},{"issue":"1","key":"10.1002\/14651858.CD008846.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2004.70.1","article-title":"The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas","volume":"70","author":"Greenwood","year":"2004","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1002\/14651858.CD008846.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0076|cit76","unstructured":"Higgins JP Deeks JJ Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD008846.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/clpt.2009.16","article-title":"Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases","volume":"85","author":"Hotez","year":"2009","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD008846.pub3-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"e0161311","DOI":"10.1371\/journal.pone.0161311","article-title":"Impact and lessons learned from mass drug administrations of malaria chemoprevention during the Ebola outbreak in Monrovia, Liberia, 2014","volume":"11","author":"Kuehne","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1002\/14651858.CD008846.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1586\/eri.13.45","article-title":"The silent threat: asymptomatic parasitemia and malaria transmission","volume":"11","author":"Lindblade","year":"2013","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12936-019-2907-7","article-title":"Mass drug administration should be implemented as a tool to accelerate elimination: against","volume":"18","author":"Mendis","year":"2019","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0082|cit82","unstructured":"Molineaux L Gramiccia G The Garki Project: research on the epidemiology and control of malaria in the Sudan Savanna of West Africa; World Health Organization (WHO) 1980 Available at apps.who.int\/iris\/bitstream\/handle\/10665\/40316\/9241560614.pdf?sequence=1&isAllowed=y"},{"issue":"1","key":"10.1002\/14651858.CD008846.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","article-title":"Review of mass drug administration for malaria and its operational challenges","volume":"93","author":"Newby","year":"2015","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD008846.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0020179","article-title":"The potential contribution of mass treatment to the control of Plasmodium falciparum malaria","volume":"6","author":"Okell","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ncomms2241","article-title":"Factors determining the occurrence of submicroscopic malaria infections and their relevance for control","volume":"3","author":"Okell","year":"2012","journal-title":"Nature Communications"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0086|cit86","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"issue":"3","key":"10.1002\/14651858.CD008846.pub3-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"e0151818","DOI":"10.1371\/journal.pone.0151818","article-title":"Cluster randomised trials in Cochrane Reviews: evaluation of methodological and reporting practice","volume":"11","author":"Richardson","year":"2016","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-397900-1.00006-2","article-title":"Control and elimination of Plasmodium vivax","volume":"80","author":"Shanks","year":"2012","journal-title":"Advances in Parasitology"},{"issue":"10","key":"10.1002\/14651858.CD008846.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.pt.2003.08.003","article-title":"Mass administration of antimalaria drugs","volume":"19","author":"Seidlein","year":"2003","journal-title":"Trends in Parasitology"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0090|cit90","unstructured":"World Health Organization The role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria; WHO; November 2015 Available at www.who.int\/malaria\/publications\/atoz\/role-of-mda-for-malaria.pdf?ua=1"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0091|cit91","unstructured":"World Health Organization Policy brief on single-dose primaquine as a gametocytocide in Plasmodium falciparum malaria; WHO; January 2015 Available at www.who.int\/malaria\/publications\/atoz\/who_htm_gmp_2015.1.pdf"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0092|cit92","unstructured":"World Health Organization Annex 1. Defining the term \"malaria case\"; WHO Malaria Policy Advisory Committee Meeting; August 2015 Available at www.who.int\/malaria\/mpac\/mpac-sept2015-terminology-annex1.pdf?ua=1"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0093|cit93","unstructured":"World Health Organization A framework for malaria elimination; WHO; March 2017 Available at apps.who.int\/iris\/bitstream\/handle\/10665\/254761\/9789241511988-eng.pdf?sequence=1"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0094|cit94","unstructured":"World Health Organization World malaria report 2020: 20 years of global progress and challenges; WHO; 2020 Available at www.who.int\/publications\/i\/item\/9789240015791"},{"key":"10.1002\/14651858.CD008846.pub3-BIB0095|cit95","unstructured":"World Health Organization Improving WHO's malaria policy-making and dissemination processes; WHO; July 2020 Available at www.who.int\/malaria\/policy\/overview\/en\/"},{"issue":"11","key":"10.1002\/14651858.CD008846.pub3-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008846","article-title":"Mass drug administration for malaria","author":"Poirot","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12 10.1002\/1465","key":"10.1002\/14651858.CD008846.pub3-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008846.pub2","article-title":"Mass drug administration for malaria","author":"Poirot","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T02:04:32Z","timestamp":1690250672000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008846.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":97,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008846.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]}}}